centered image

Doctor’s Insights on Deprescribing in Geriatric Medicine

Discussion in 'Doctors Cafe' started by Yumna Mohamed, Sep 17, 2024 at 9:46 PM.

  1. Yumna Mohamed

    Yumna Mohamed Bronze Member

    Joined:
    Jun 14, 2024
    Messages:
    671
    Likes Received:
    0
    Trophy Points:
    940
    Gender:
    Female
    Practicing medicine in:
    Egypt

    Understanding the Need for Deprescribing in Geriatrics

    1. Polypharmacy and Its Impact on the Elderly

    Polypharmacy is common among older adults, and studies have shown that nearly half of elderly patients are on five or more medications simultaneously. This over-reliance on medications can lead to several complications, including:

    • Increased risk of adverse drug reactions (ADRs): Older adults are more vulnerable to ADRs because their bodies process medications differently than younger individuals. Reduced renal and hepatic function, for instance, can impair drug metabolism and clearance.
    • Drug-drug interactions: The more medications a patient takes, the higher the chance of drug interactions, which can result in anything from mild discomfort to life-threatening conditions.
    • Medication nonadherence: Elderly patients often have difficulty keeping track of multiple medications, which increases the likelihood of nonadherence or dosing errors.
    • Decreased quality of life: Taking a large number of medications can be physically and psychologically burdensome for elderly patients, detracting from their overall well-being.
    2. The Ethical Imperative to Deprescribe

    Healthcare providers have an ethical responsibility to ensure that medications are doing more good than harm. Deprescribing is not just about removing unnecessary drugs but also about enhancing patient quality of life by ensuring treatments align with a patient’s current goals and preferences. For geriatric patients, particularly those with limited life expectancy or comorbidities, deprescribing can lead to significant improvements in their day-to-day functioning.

    3. Deprescribing as a Collaborative Process

    Deprescribing is not a simple decision but a collaborative process that involves the patient, caregivers, pharmacists, and the prescribing physician. This teamwork ensures that the benefits of deprescribing are maximized while minimizing potential harm. In geriatric care, it’s essential to communicate openly with the patient and their family to ensure that they understand the rationale behind deprescribing and are comfortable with the approach.

    Steps in the Deprescribing Process

    1. Comprehensive Medication Review

    The first step in deprescribing is a thorough medication review, which allows the healthcare provider to assess all of the medications the patient is currently taking. This review should include:

    • All prescribed medications: Including over-the-counter drugs, supplements, and herbal remedies.
    • Indication for each medication: What is each medication being used to treat, and is it still necessary?
    • Duration of use: How long has the patient been taking the medication, and does the duration still make sense given their current health status?
    • Side effects: Are there any new or ongoing side effects that could be attributed to the medications?
    A comprehensive review will help the healthcare provider identify which medications may no longer be necessary or could be contributing to polypharmacy-related problems.

    2. Assessing Risk vs. Benefit

    The decision to deprescribe must be based on a careful analysis of the risk versus benefit for each medication. Medications that were once beneficial may now pose more risks than benefits, especially as a patient’s health declines. For example:

    • Statins may no longer be necessary for a 90-year-old with a limited life expectancy, especially if they’ve experienced side effects like muscle pain or cognitive impairment.
    • Anticholinergic drugs, which are commonly used for conditions such as overactive bladder, may be contributing to confusion, falls, or dry mouth in elderly patients. The healthcare provider must consider whether continuing the medication will improve the patient’s quality of life or whether deprescribing will have a net positive effect.
    3. Prioritizing Medications to Deprescribe

    Once the medication review is complete, the next step is to prioritize which drugs should be considered for tapering or discontinuation. Some medications should be deprescribed first due to their high risk of adverse effects, including:

    • Benzodiazepines: These drugs are often prescribed for anxiety or sleep disorders but carry a high risk of falls, cognitive decline, and dependence in the elderly.
    • Proton pump inhibitors (PPIs): Long-term use of PPIs has been linked to increased risks of fractures, kidney disease, and infections in elderly patients.
    • Antipsychotics: Frequently prescribed for behavioral symptoms of dementia, these drugs have a high risk of causing falls, sedation, and metabolic side effects. Prioritizing medications allows for a gradual and cautious deprescribing process, ensuring that patient safety is the top priority.
    4. Tapering and Monitoring

    Some medications, such as benzodiazepines or certain antihypertensives, should not be stopped abruptly due to the risk of withdrawal or rebound effects. Tapering these medications slowly over time is crucial to prevent withdrawal symptoms and to ensure the patient adjusts to the changes.

    During the tapering process, it’s important to closely monitor the patient’s response. Regular follow-up appointments allow the healthcare provider to assess any withdrawal symptoms, changes in the patient’s condition, or potential need for dose adjustments.

    Challenges in Deprescribing

    1. Patient and Caregiver Resistance

    Many elderly patients, along with their caregivers, may resist deprescribing because they believe that more medications equate to better care. This misconception can be a significant barrier to deprescribing, and it requires education and reassurance. Providers must emphasize that deprescribing is not about “giving up” but about optimizing the patient’s health and quality of life.

    2. Fear of Symptom Recurrence

    Another challenge is the fear that discontinuing certain medications may lead to a recurrence of symptoms. For example, a patient who has been on a proton pump inhibitor for years may worry that stopping it will lead to the return of acid reflux. In such cases, healthcare providers can offer alternative treatments or lifestyle changes that may be equally effective without the risks associated with long-term medication use.

    3. Navigating Multiple Prescribers

    It’s not uncommon for geriatric patients to have multiple specialists prescribing different medications. This can complicate the deprescribing process, as the primary care physician may not be familiar with all the medications the patient is taking. Effective communication between healthcare providers is crucial to ensure a coordinated approach to deprescribing.
     

    Add Reply

Share This Page

<